Literature DB >> 7191614

The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women.

T Rud.   

Abstract

The present investigation was performed to study the urodynamic effects of hormones on the lower urinary tract in women. Twenty-four stress incontinent and 6 continent women were randomly given E2 and E3 orally in doses of 4--8 mg per day for 3 weeks. Another group of 8 women were given a single i.m. injection of 1000 mg gestagen. All the women were examined with simultaneous urethrocystometry, including urethral pressure profile measurement, before and after treatment. After estrogen treatment the transmission of intraabdominal pressure to the urethra increased. Furthermore, there was a significant increase in maximum urethal pressure and urethral length at rest. After gestagen treatment no significant changes of the recorded parameters were observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191614     DOI: 10.3109/00016348009155409

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  17 in total

1.  Relationship between serum estradiol and follicle-stimulating hormone levels and urodynamic results in women with stress urinary incontinence.

Authors:  Ki Hoon Ahn; Tak Kim; Jun Young Hur; Sun Haeng Kim; Kyu Wan Lee; Young Tae Kim
Journal:  Int Urogynecol J       Date:  2011-01-27       Impact factor: 2.894

2.  Long-term observation of the detrusor smooth muscle in rats. Its relationship to ovariectomy and estrogen treatment.

Authors:  B Eika; L N Salling; L L Christensen; A Andersen; S Laurberg; C C Danielsen
Journal:  Urol Res       Date:  1990

3.  Comparative studies on urethral function.

Authors:  M Habib; L Krasnopolsky; S Gaafar; R M Levin
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 4.  Sex hormones and the female urinary tract.

Authors:  A Miodrag; C M Castleden; T R Vallance
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

5.  Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways.

Authors:  J N Cornu; B Merlet; O Cussenot; G Cancel-Tassin; C Ciofu; G Amarenco; F Haab
Journal:  World J Urol       Date:  2010-07-14       Impact factor: 4.226

6.  A study assessing the quality of life related to voiding symptoms and sexual functions in menopausal women.

Authors:  Ji Youn Chun; Kweon Sik Min; Dong Il Kang
Journal:  Korean J Urol       Date:  2011-12-20

Review 7.  Oestrogen therapy for urinary incontinence in post-menopausal women.

Authors:  June D Cody; Madeleine Louisa Jacobs; Karen Richardson; Birgit Moehrer; Andrew Hextall
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 8.  Rational prescribing for postmenopausal urogenital complaints.

Authors:  I Milsom
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

9.  Distribution of estrogen receptors alpha and beta mRNA in mouse urogenital tissues and their expression after oophorectomy and estrogen replacement.

Authors:  Michael E Carley; David J Rickard; John B Gebhart; Maurice J Webb; Karl C Podratz; Thomas C Spelsberg
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-02-27

10.  Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register.

Authors:  Anastasia Iliadou; Ian Milsom; Nancy L Pedersen; Daniel Altman
Journal:  Fertil Steril       Date:  2008-08-15       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.